Notes to the SCC | O'Shaughnessy's

Epidiolex Weighs in at Schedule V

But CBD remains on Schedule I, due to its supposed abuse liability. “DEA’s decision to move...

The fact that studies with negative results can be ignored —not published in the literature or...

Thanks to Vicki Mossman for alerting us to this story of shameless greed by drug industry...

Steve Robinson, MD, forwards a paper in Lancet, “Stuctural Racism and health inequities in...

A Sept. 17 op-ed in the NY Times calls for big changes in the Drug Enforcement...